Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies

    ... of PNH is chronic, complement-mediated, intravascular hemolysis , which results in anemia, hemoglobinuria, fatigue, and other hemolysis-related disabling symptoms. In addition, the peculiar thromboembolic ...

    Research Article last updated 10/02/2012 - 9:57am.

  2. Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis

    ... , she became pregnant. She developed breakthrough hemolysis at 20 weeks gestation. Pharmacokinetic and pharmacodynamic ... Escalation of her eculizumab dose successfully controlled hemolysis and restored therapeutic eculizumab level and activity. She ...

    Research Article last updated 06/23/2015 - 9:29am.

  3. Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria

    ... that prevents complement-mediated intravascular hemolysis . However, a considerable fraction of PNH patients show ... we provide experimental evidence for such extravascular hemolysis and demonstrate that PNH erythrocytes from anti-C5-treated patients ...

    Research Article last updated 07/07/2015 - 2:14pm.

  4. Paroxysmal Nocturnal Hemoglobinuria: A Complement-Mediated Hemolytic Anemia

    ... for thrombosis and marrow failure. The hemolysis is largely mediated by the alternative pathway of complement. ...

    Research Article last updated 06/23/2015 - 9:32am.

  5. A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.

    ... complement activation leading to intravascular hemolysis and an inflammatory prothrombotic state. The EXPLORE study aimed ... (BMF) syndromes and the effect of PNH clone size on hemolysis. METHODS: Patients, selected from medical office chart reviews, ...

    Research Article last updated 11/21/2013 - 11:54am.

  6. A Prospective Multicenter Study of Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure.

    ... complement activation leading to intravascular hemolysis and an inflammatory prothrombotic state. The EXPLORE study aimed ... (BMF) syndromes and the effect of PNH clone size on hemolysis. Methods: Patients, selected from medical office chart reviews, had ...

    Research Article last updated 10/22/2013 - 3:42pm.

  7. Self-injected PNH therapy on the horizon

    ... percent inhibition (range 96 percent to 100 percent) of hemolysis at 24 hours. "The company's strategy and product profile appears ...

    Article last updated 07/07/2016 - 9:40am.

  8. Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review

    ... action of complement. Patients experience intravascular hemolysis , smooth muscle dystonia, renal failure, arterial and pulmonary ... of eculizumab , which brings benefits in terms of hemolysis, quality of life, renal function, thrombotic risk, and life ...

    Research Article last updated 04/07/2015 - 12:36pm.

  9. Complement Blockade with a C1 Esterase Inhibitor in Paroxysmal Nocturnal Hemoglobinuria

    ... These patients experience both intra- and extravascular hemolysis in the context of underlying complement activation. Currently eculizumab effectively blocks the intravascular hemolysis PNH. There remains an unmet clinical need for a complement inhibitor ...

    Research Article last updated 08/04/2014 - 8:13am.

  10. Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition

    ... that result in both intravascular and extravascular hemolysis . Free hemoglobin leads to nitric oxide depletion ... drug that in PNH has been shown to block complement-mediated hemolysis, reduce transfusion dependency, reduce thromboembolic complications ...

    Research Article last updated 11/05/2013 - 12:37pm.